Man Group »

An2 Therapeutics shares owned by Man Group

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Man Group from 13F filings

Historical chart of Man Group investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Man Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Man Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $376k 18k 20.49

More positions owned by Man Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Meta Platforms Cl A (META)
Qualcomm (QCOM)
Alphabet Cap Stk Cl C (GOOG)
Coca-Cola Company (KO)
Mastercard Incorporated Cl A (MA)
Equinix (EQIX)
Micron Technology (MU)
Merck & Co (MRK)

View all positions for Man Group

Top funds holding An2 Therapeutics

RA Capital Management
Citadel Advisors
Frazier Life Sciences Management
BVF
Henderson Group
Avidity Partners Management
Octagon Capital Advisors
Vanguard Group
Adage Capital Partners GP
BlackRock
Susquehanna International
Geode Capital Management
Acadian Asset Management
Walleye Trading Advisors
Alyeska Investment Group

View all funds holding An2 Therapeutics